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ABSTRACT
DIFFERENTIATION OF HEPATOCYTE LIKE CELLS
FROM IMMORTALIZED MOUSE EMBRYONIC
FIBROBLASTS HARBORING LARGE T ANTIGEN
Umur Keles¸
M.S.in Molecular Biology and Genetics
Advisor: Prof. Dr. I˙hsan Gu¨rsel
Co-advisor: Prof. Dr. Mehmet O¨ztu¨rk
January, 2015
Genetic and acquired liver diseases are generally progressive and life threatening
with limited curative therapy options. Although organ transplantation is the
most potent treatment, number of patients waiting for organ transplant far
outnumbers the potential suitable donors. Recently, new alternative methods
have been developed to generate functional hepatocytes which can directly be
administered to patients. Generating hepatocytes from different cells derived
from patient has been one of the most promising alternative. Direct conversion
of terminally differentiated cells into hepatocyte like cells has been reported
previously. However, hepatocyte differentiation from SV40 Large-T antigen
expressing immortalized Mouse Embryonic Fibroblasts has not been reported.
To this end, first we have evaluated the effects of individual and combined
retroviral expression of liver lineage determining transcription factors: Hnf4α,
Foxa2 and Foxa3. Single factor transduced immortal MEFs gave little or no
significant epithelial marker expression. These conditions were also insufficient
to induce liver specific phenotype. However, combined expression of either
Hnf4α+Foxa2 or Hnf4α+Foxa3 have resulted in an increased epithelial and
liver specific characteristics such as albumin expression and glycogen storage.
To elucidate epigenetic background of this process we genotyped transgenic
mouse strains with conditional knockout alleles of histone variants. Histone
variant H3.3A conditional knockout immortal MEFs were also infected with
Cre expressing retroviral vectors. Our studies indicated that, Large-T antigen
immortalized MEFs can be transdifferentiated by using the protocol designated
for primary MEFs. Additionally, by isolating and immortalizing genetically
determined MEFs, we have established cell lines ready for understanding the
roles of histone variants on transdifferentiation.
iii
iv
That will be the foundation of subsequent studies delineating effects of histone
variants on hepatocyte differentiation from MEFs.
Keywords: Induced hepatocyte, SV40, Immortal MEF, Hnf4α, Foxa2,
Foxa3,direct conversion, H3.3A.
O¨ZET
SV40 BU¨YU¨K T ANTI˙JENI˙ I˙C¸EREN I˙MMORTALI˙ZE
FARE EMBRI˙YONI˙K FI˙BROBLASTLARININ
HEPATOSI˙T BENZERI˙ HU¨CRELERE
DO¨NU¨TU¨RU¨LMESI˙
Umur Keles¸
Moleku¨ler Biyoloji ve Genetik, Yu¨ksek Lisans
Tez Danıs¸manı: Prof. Dr. I˙hsan Gu¨rsel
Es¸ Danıs¸man: Prof. Dr. Mehmet O¨ztu¨rk
Ocak, 2015
Edinilmis¸ ve genetik kaynaklı karacig˘er hastalıkları genellikle ilerleyici ve hayati
tehlike arz eden o¨zelliktedir. Organ transplantasyonunun en iyi sonuc¸ veren
tedavi olarak kabul edilmesine rag˘men, hasta sayısı nakile uygun dono¨r sayısını
as¸maktadır. Somatik hu¨crelerin dog˘rudan indu¨klenerek hepatosit benzeri
hu¨cre elde edilmesi yeni umut vaat eden yo¨ntemlerden biridir ve o¨nceden
tanımlanmıs¸tır. Ancak hepatosit benzeri hu¨crelerin, SV40 bu¨yu¨k T-antijeni
ile immortalize edilmis¸ Fare Embriyonik Fibroblastlardan (FEF) elde edilmesi
henu¨z c¸alıs¸ılmamıs¸tır. Bu amac¸la, karacig˘erin embriyonik farklılas¸masında
rol oynayan Hnf4α, Foxa2 ve Foxa3 transkripsiyon fakto¨rlerinin retroviral
vekto¨rlerle ayrı ve farklı kombinasyonlarla o¨lu¨msu¨z FEF hu¨crelerine verilmesinin
etkilerini inceledik. Bir transkripsiyon fakto¨ru¨yle enfekte edilen FEF hu¨creleri
epitel ve hepatosit hu¨cre karakterlerini moleku¨ler olarak o¨nemli miktarda
go¨stermediler. Ancak, Hnf4α+Foxa2 ya da Hnf4α+Foxa3 kombinasyonu
o¨lu¨msu¨z FEF hu¨crelerinde epitelyal E-cadherin ifadesi; albumin ifadesi ve
glikojen depolanması gibi hepatosit karakterlerinin ifadesini uyardıg˘ı go¨zlendi.
Bu su¨reci etkileyen epigenetik mekanizmaların aydınlatılması ic¸in, histon
varyantlarından kos¸ullu olarak gen ablasyonu yapılabilen transgenik farelerin
genotiplemesi yapıldı. Ayrıca, histon varyantı H3.3A geninde kos¸ullu olarak
gen ablasyonu yapılabilen o¨lu¨msu¨z FEF hu¨creleri, Cre rekombinaz genini
ifade eden retroviral vekto¨rlerle enfekte edilmis¸tir. Bu c¸alıs¸mada Bu¨yu¨k
T-antijeni ile immortalize edilmis¸ FEF hu¨crelerinin, primer FEF hu¨creleri ic¸in
dizayn edilmis¸ protokolu¨ kullanarak, hepatosit benzeri hu¨crenin dog˘rudan elde
edilebildig˘i kanıtlanmıs¸tır. Ayrıca, genetik olarak belirlenmis¸ hayvanlardan FEF
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hu¨creleri izolasyonu ve immortalizasyonu yaparak, histon varyantlarının hepatosit
transdifferensiyasonundaki rolu¨nu¨ anlamak ic¸in o¨nemli bir arac¸ elde edilmis¸tir.
Anahtar so¨zcu¨kler : I˙ndu¨kte edilmis¸ hepatosit, SV40, Hnf4α, Foxa2, Foxa3,
dog˘rudan hu¨cre do¨nu¨s¸u¨mu¨, H3.3A.
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Chapter 1
Introduction
1.1 Therapy in end-stage liver diseases
1.1.1 Tissue transplantation
Liver is a multifunctional organ that orchestrates hundreds of physiological
process simultaneously such as glycogen storage, xenobiotic detoxification,
lipid metabolism and protein secretion [1]. Genetic and acquired liver
diseases may be life threatening ; and, most of the time, orthotopic liver
transplantation(OLT) is the only therapy option. Liver transplantation centers
gives higher priority to patients with end stage liver diseases: chronic liver
diseases with hepatocellular carcinoma, cholangiocarcinoma, fulminant liver
failure; chronic liver diseases with, portal hypertension, hepatic encephalopathy
and hepatopulmonary syndrome [2]. However, number of patients waiting for
liver transplants far outnumbers the potential liver donors; and, many patients
progress to liver failure and death while waiting [2, 3, 4]. Furthermore, liver
transplantation shows moderate tissue compatibility in patients, which decreases
the success rate of allogenic liver transplantation [5].
Alternative to whole organ transplantation, cellular therapies such as
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transplantation of primary hepatocytes isolated from human livers has been
proved to be a potential tool[6]. Moreover, in regenerative medicine, promising
methods have been developed to create functional cells of specific organs such
as, heart, kidney, pancreas and liver. Such methods mostly based on stem cells,
which can give rise to wide variety of functional cells in an organisms[7, 8, 9, 10].
Accordingly, seeking new methods to obtain functional hepatocytes from different
sources has been intensively studied.
1.1.2 Cell transplantation
Recent studies on cellular therapy for distinct liver diseases is encouraging. One of
the proposed methods is isolation and transplantation of hepatocytes. Although
the primary hepatocytes were transplanted to patients and promising results were
obtained, isolated hepatocytes are mostly short in number, show varying quality
and cannot be expanded in vitro [11].
Adult liver harbors bipotential cells that resides in bile terminal ductules (canals
of hering). These cells are considered as adult liver stem/progenitor cells (LSPC)
which can give rise to both hepatocytes and cholangiocytes. LSP cells are
activated when the liver is damaged from various source [11]. Though limited
number of LSPCs are found in adult liver, in vitro expansion of progenitors has
been demonstrated by cell surface marker mediated isolation. Furthermore, these
progenitor cells successfully repopulate liver in vivo [12].
In 1992, scientists have developed an artificial liver system called Extracorporeal
Liver Assisting Device (ELAD) in order to extend life expectancy of patients.
ELAD system exploits human C3A cell lines (HepG2 hepatoma derived cell line)
to supplement and detoxify patient’s blood. This was achieved by perfusion of
patient’s blood into hollow fiber cartriges containing cultured C3A cells. Cartrige
system prevents hepatoma cells to transfuse into patient’s bloodstream [13].
Although the clinical trials have resulted increased survival rate and life quality, it
is an exhausting therapy course that patients are dependent to perfusion sessions
with ELAD.
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Hepatocyte-like cells can also be derived from Embryonic Stem Cells (ESCs).
Inner cell mass obtained from preimplantation embryos can be expanded in
special culture conditions without differentiation. Next, lineage determination
through embryoid bodies, endoderm , hepatoblasts and hepatocyte-like states
are induced with special conditions [14]. Despite the potential, derivaiton of
fertilized embryos are still an ethical issue and during differentiation, hepatocyte
yield drops dramatically.
Another potential source of functional hepatocytes are circulating stem cells
consisted of Hematopoietic Stem Cells (HSCs) and Mesenchymal Stem Cells
(MSCs). Several articles has shown that, upon liver resection, inflammatory
stimuli and ischemic damage in liver can induce bone marrow-derived stem
cell mobilization [15, 16, 17]. Pilot studies have demonstrated that infusion of
autologous MSCs to patients with end-stage liver disease have beneficial effects
[18, 19].
In 2006, terminally differentiated mouse somatic cells have been successfully
reprogrammed into pluripotent stem cells by using defined transcription factors:
Oct4, Sox2, Klf4 and c-Myc. This study started a new era for regenerative
medicine, since vast amount of cell types can be achieved by differentiating
induced pluripotent stem cells (iPSCs) [20]. In following years, hepatocyte-like
cells have been successfully differentiated from human and mouse iPSCs. Human
derived iPSCs were differentiated into hepatocytes and successfully transplanted
to immunodeficient mouse liver [21]. Furthermore, vascularized liver buds were
generated from human iPSCs and showed functional liver characteristics in vivo
[22].
1.1.3 Transdifferentiation of hepatocyte-like cells
Although iPSCs paved the way through obtaining functional parenchyma cells,
reprogramming the cells into pluripotent state followed by differentiation to
desired cell phenotype is a time consuming and laboring process. A new method
was explored by two different groups in 2011, which aims to directly differentiate
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somatic fibroblasts into hepatocyte-like cells [23, 24].
Obtaining hepatocyte-like cell from iPSCs requires two reprogramming steps
including: induction of pluripotency from terminally differentiated cells and
chemical mediated differentiation into desired cell phenotype. Although this
two-step process is already optimized, particularly the latter step shows varying
success rate which is deeply affected by: growth factors /chemical substances used
in the process and manipulation time [25]. On the contrary, direct induction
of terminally differentiated cells into hepatocyte is one single step mediated
by transcription factors. Using a single conditioned differentiation medium
supplemented with EGF and HGF favor differentiation and proliferation of
hepatocyte-like cells.
Direct differentiation of somatic cells requires global change of gene expression.
Transcription factors are mostly the key regulators in reprogramming.
During liver development many transcription factors involves in differentiation
nonexclusively; but, they rather forms stringent and complex combinations to
induce liver specific gene expression. There are set of factors playing role in liver
development: winged helix family proteins Hnf3α, β and γ (Also called Foxa1,
Foxa2 and Foxa3 respectively); Homedomain proteins Hnf1α, Hnf1β; nuclear
hormone receptor family Hnf4α, COUP-TFII, LRH-1, FXRα and PXR; Leucine
zipper containing factor C/EBPα; Hnf6; zinc finger transcription factors Gata4
and Gata6 [26].
In order to transdifferentiate somtaic cells into hepatocyte like cells, one group
from Japan has tested twelve transcription factors some of which were mentinoed
above: Hex, Gata4, Gata6, Tbx3, Cebpα, Hnf1α, Hnf1β, Foxa1, Foxa2,
Foxa3, Hnf4α and Hnf6. These factors were delivered into Mouse Embryonic
Fibroblasts (MEFs) and adult tail tip fibroblasts (TTFs) by using retroviral
vectors. By using HGF and EGF supplemented differentiated medium, they have
successfully obtained hepatocyte-like cells which exhibit increased liver specific
gene expression profile. Retracting transcription factors have resulted that, Hnf4α
together with either Foxa1, Foxa2 or Foxa3 constitutes minimum combination
required for direct differentiation of somatic MEF cells. These transdifferentiated
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cells are so called induced Hepatocyte-Like (iHEP) cells and can be expanded in
vitro without any genetic instability. Obtained hepatocyte-like cells also rescued
fumarylacetoacetate-hydrolase-deficient (Fah -/-) liver failure mouse model [24].
With few exceptions, similar transcription factors were used in direct
differentiation protocol by another group in China: Gata4, Foxa1, Foxa2, Foxa3,
Hnf1α, Hnf4α, Hnf6, Hlf, Hex, Jarid2, Coup-TF1, Lrh1, Fxr and Pxr. Then,
these factors were cloned in lentiviral vectors for gene delivery. Different from
experiments mentioned above, primary MEF cells were p19 deleted (p19-/-)
which has disrupted p53 pathway and yields expandable iHEP cells. In this
set of experiments, scientists reduced number of transcription factors to a final
combination of: Hnf1α, Foxa3 and GATA4. Generated iHEP cells are also
able to rescue Fah deficient mice [23]. Same group has transdifferentiated
human fibroblasts into human induced hepatocyte like cells (hiHEPs) by using
three factors in combination: Hnf1α, Hnf4α and Foxa3. Since human derived
hepatocytes are mostly not expandable, SV40 large T antigen immortalized
fibroblasts were used for unlimited hiHEP culture [27]. This study also proved
that induction of hepatocyte like cells from human fibroblasts differs from
induction of MEFs in terms of transcription factor combination.
These articles have proven that most potent transcription factor combinations
are composed of: Hnf4α, Hnf1α, Foxa1 (Hnf3α), Foxa2 (Hnf3β), Foxa3 (Hnf3γ)
and Gata4.[23, 24] Regulation of many hepatocyte specific genes are mediated
strongly but not exclusively by Hnf4α, Hnf1β and Hnf1α transcription factors.
Especially, Hnf4α alone is indispensible for development that, its deletion leads
to growth arrest at gastrulation because of visceral endoderm dysfunction [28].
These factors can also reciprocally stimulate each other by establishing a feed
forward loop. Hnf3 factors, which are also called Foxa proteins (Foxa1, 2 and
3) are essential for direct chromatin regulation to facilitate liver specific gene
expression(FigureB.2) [26].
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Figure 1.1: Interaction of liver enriched transcription factors in embryonic
development and maturity. Effects of Hnf4α deletion in development and
adulthood is represented in lower diagrams (adapted from Kyrmizi et. al, Genes
& Development, 2006)[26]
In addition to the the developmental roles, given transcription factors are essential
for normal liver function in adults. For example, deletion of Hnf4α and Hnf1α
factors cause glycogen storage failure in mice. Epithelial phenotype is also
severely disrupted in Hnf4α deleted mice. In adult mice, although Foxa3 null
mice show decreased hepatic Glut2 expression, Foxa1 knockout mice and Foxa2
fl/fl conditional knockout mice show no severe phenotypes except hypoglycemia
[29]. Besides the direct actions of transcription factors, a complex crosstalk
between individual transcription factors have different phenotypic effect on cells.
During direct differentiation, only stringent combination of transcription factor
meet minimum criteria for hepatocyte-like phenotype [24, 23, 27].
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In summary, specific transcription factors should be delivered to the cells
with stringent combination to induce a liver specific function, just as in iPSC
generation process. However, required criteria for direct induction of hepatocytes
can be crudely represented as two major steps: 1- relaxation of chromatin
structure by a liver lineage transcription factor which can modulate chromatin
such as Foxa proteins.; 2- a key hepatocyte master regulator transcription factor
for activating liver specific gene expression such as Hnf4α.
1.1.4 Cellular immortalization in reprogramming
Immortalization of primary or early passage of cells without differentiation or
disruption of phenotype is an invaluable tool for functional studies. Many human
or rodent derived cells have been successfully immortalized [30]. There are two
most prominent ways of immortalization: 1- blocking of p53, pRb pathway to
promote cell cycle progression; 2- activating telomerase which results in elongation
of telomeric repeats. Increased telomeric sequences protects cells from crisis
caused by shortened telomeres. While inactivation of p53 and pRb pathway is
enough to immortalize most of the rodent tissues, additional telomerase activation
is required for human derived cells due to lack of hTERT activity in many tissues
[31].
A widely used immortalization method is inactivation of p53 and pRb pathway
by SV40 large T-antigen expression. SV40 is an abbreviation for Simian Virus
40 which contains three elements: 17K T-antigen, small t-antigen and large
T-Antigen. Large T-antigen can bind and inactivate heatshock chaperone 70
(hc70), Rb family tumor suppressor proteins (pRb, p107 and p130) and tumor
suppressor p53 (Figure1.2). Large T-antigen can be transiently or permanently
delivered to the desired cells. Many rodent cells can be immortalized merely by
overexpression of Large T-antigen [32].
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Figure 1.2: Effects of SV40 large T antigen in intracellular pathways (adapted
from Ahuja et. al, Nature, 2005)[32]
Inhibition of p53 pathway has additional benefits on reprogramming other than
immortalization of the cells. Inventors of iPSCs, Shinya Yamanaka and his
colleagues have explored that heterozygote and homozygote deletion of p53
increase iPSC colonies from MEFs by up to 10 and 40 folds respectively even in
the absence of c-Myc factor. [33] Similarly, p53 sh-RNA expression was shown to
significantly increase numbers of hiPSC colonies derived from human fibroblasts.
However in the same study, ectopic expression of hTERT did not yielded increased
number iPSC colonies [34]. In another study, transient SV40 large T-antigen over
expression in peripheral mononuclear cells increased iPSC colonies and reduced
reprogramming duration [35].
During cellular differentiation, pRb also plays critical roles. In addition to
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gate-keeper role on restriction point of cell cycle, it can also regulates chromatin
structure by distinct mechanisms: 1- direct recruitment of co-repressors when
bound to gene promoters; 2- direct interaction of polycomb group (PcG)
repressor proteins; 3-genomewide regulation and maintenance of heterochromatin
structure. Deletion of pRb cause inhibition of differentiation, and leads to cellular
expansion and tumorigenesis [36].
Besides the elimination of p53 and pRb, mouse epithelial cells were shown to be
expanded when p19 is deleted [37]. In the same study, mouse hepatocytes derived
from p19 knockout mice (p19-/-) were cultured without losing genetic stability
and cell characteristics. These cells also successfully populated in liver without
tumor formation. Same knockout model was utilized in direct differentiation
studies that, differentiated cells were expandable in vitro [23]. p19 acts as a p53
activator by inhibiting the Mdm2, a p53 inhibitor.
All studies indicates that, during reprogramming, p53, pRb and p19 tumor
suppressor proteins mostly acts as a barrier on dedifferentiation process. This
results encouraged us to inspect the effects of p53/pRb immortalization on direct
differentiation. To best of our knowledge, there is no study aiming identification
of phenotypinc effect of disrupted p53/pRb mouse cells on direct hepatocyte
differentiation.
1.2 Cellular reprogramming and epigenetics
1.2.1 Regulation of cellular differentiation by epigenetic
mechanisms
Cellular reprogramming can be simply considered as alterations in gene expression
pattern which is controlled mainly by two protein families: 1- Transcription
factors, which physically interacts with genomic DNA and directly modulates
gene expression patterns by affecting transcription machinery; 2- epigenetic
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regulators which affect gene expression patterns in various ways such as histone
modifications and DNA metylation [38, 39]. These two concepts can be best
explained with generation of induced Pluripotent Stem Cells (iPSCs). Terminally
differentiated somatic cells are forced to change their gene expression pattern
by ectopic expression of four transcription factors Oct4, Sox2, Klf4 and c-Myc.
After the induction, chromatin architecture switches to more ”open” state, which
potentially exposes numerous regulatory sites of various lineage determining
genes. Both ESCs and iPSCs are more abundant for active chromatin marks, such
as modified histones; H3K4Me3 and H3K9Ac; and, global DNA hypomethylation.
Contrarily, terminally differentiated somatic cells show prevalent heterochromatin
status accompanied by repressive chromatin marks such as H3K27Me3. Thus,
induction of pluripotency from terminally differentiated cells has been intensively
studied to elucidate the complex relationship between defined transcription
factors (Oct4, Sox2, c-Myc and Klf-4) and epigenetic status of induced cells
[40]. To this end, potential epigenetic barriers acting in differentiated-pluripotent
transition have been revealed including H3K9me3/2, H3K27me3, insufficient
histone acetylation on H3K9 and DNA hypermethylation [40].
Generation of iPSCs aims to establish a chromatin state which allows to
apply any cell differentiation protocol. However, induced pluripotent stem cells
show varying levels of epigenetic memory inherited from cells which undergo
dedifferentiation. Attempts to erase the memory of target cells can affect the
yield and quality of iPSCs [40, 41]. For example, in an sh-RNA mediated loss of
function study, DOT1L, a H3K79 methyl transferase, has been discovered as a
specific barrier to iPSC formation [42].
Besides generation of iPSCs, direct differentiation of somatic cells require
profound epigenetic alterations in order to repress genes peculiar to original cells
and to activate genes related with desired cell types. In this concept, global
epigenetic modifiers have been shown to affect transdifferentiation susceptibility
of cells [43]. In order to increase fibroblast responsiveness to Wnt3a for
osteogenesis differentiation, scientists have used 5’-aza-dC and trichostatin-A
which are inhibitor of DNMT and inhibitor of HDAC respectively.
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1.2.2 Epigenetic regulations on liver specific gene expression
and lineage determination
Complex functions in liver mainly regulated by liver enriched transcription
factors during development and in maturity. Recruitment and activation of
these factors require cooperation with histone modifiers. Liver enriched Hnf4α,
for example, can interact with CBP, SRC1 and p300, which leads to increased
transcriptional activity of Hnf4α [44]. Another striking example is Hnf3 (FoxA)
family transcription factors. These factors can directly affect conformation
of chromatin structures of liver specific genes such as Albumin and Alpha
Fetoprotein and upregulate their expression without recruiting any coactivator.
To to this, FoxA factors turns heterochromatic domains into open nucleosomal
state which allows other factors to bind DNA [45].
Global epigenetic modifiers also affects liver specific gene expression in
differentiated cell. For example, hepatoma cell lines treated with either
5-aza-2’-deoxycytidine (5-aza-dC, a histone methylase inhibitor) or Trichostatin A
(histone deacetylase inhibitor) resulted in increased xenobiotic mechanism related
gene expressions [46]. Liver enriched transcription factors can also be regulated
by global epigenetic modifiers. As an example, inhibition of HDAC in hepatoma
cells induces growth arrest and leads to upregulation of liver specific transcription
factors C/EBPα, HNF1α, HNF3α, HNF3β and HNF4α [47]. Differentiation of
pluripotent embryonic stem cells (ESCs) and mesenchymal stem cells into liver
specific phenotype can be facilitated by inhibiting the HDACs and DNMTs [48].
1.2.3 Histone variants and reprogramming
Histone variants are noncanonical histone molecules which share varying level
of homology with canonical histones: H1, H2A, H2B, H3 and H4 (Figure
1.3).Histone variants are recruited to nucleosomes by chromatin remodeling
complexes and replace with their matching canonical histone molecules (e.g H3.3
variant replace with H3) [49]. Identified histone variant specific chaperones guide
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these remodeling complexes to where a nucleosme exchange is required. Unlike
the canonical histones, most of the variants can be dynamically deposited to
chromatin structure in a replication independent manner. Therefore, vast number
of studies have been ongoing to elucidate roles of histone variants in dynamic
chromatin structure. Some of the identified functions of histone variants are
activation/repression of gene transcription, DNA damage repair, chromosome
segregation and chromosome inactivation [50].
Histone H2A.Z is a highly conserved variant showing 60% of homology with core
histone H2A [51]. It replaces H2A core histone in replication independent manner
by two remodeling complexes: SWR-C and INO80. H2A.Z can mediate gene
activation and gene silencing upon deposition into chromatin [50]. Same variant
also protects euchromatin from being invaded by spread of heterochromatin [52].
One of the most significant roles of H2A.Z is its ability to poise gene for expression
by localizin in promoter region. Nucleosomes in poised genes can easily be
replaced by transcription machinery upon activatio of gene [50]. Another very
interesting role attributed to H2A.Z is its cooperation with Foxa2 to generate
nucleosome depleted regions in order to facilitate endoderm lineage determination
in ESCs [53].
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Figure 1.3: Histone variants and difference from their canonical histone
counterparts. (adapted from Maze et. al, Nature, 2014)[49]
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Another highly conserved histone variant H3.3 differs only four amino acids from
H3 core histon [50]. Two different genes, H3.3A and H3.3B codes for variant
H3.3 protein. Deposition of H3.3 variants into genome is mediated by specific
chaperones HIRA and Daxx.[54] Although several roles were attributed to H3.3, a
well characterized function is activation of gene expression by H3.3 deposition into
Transcription Start Sites (TSSs) of actively transcribed gene promoter (figure 1.4)
[55]. Since embryonic development is tightly regulated in transcriptional level,
active deposition of H3.3 indicates a crucial role in developmental process. This
concept was proven in several studies. Deletion of H3.3B in mice causes severe
developmental retardation, chromosome segregation defects and infertility [56].
In another report, loss of H3.3 has been shown to cause over-condensation and
mis-segregation of chromatin [57]. In regenerative medicine, mRNA of maternal
H3.3 has been found to have an indispensible role in reprogramming of cells with
Somatic Cell Nuclear Transfer (SCNT) technology [58]. In a report, H3.3 has
been shown to protect epigenetic memory of active gene states, and mutant H3.3
is related with decresed epigenetic memory [59].
Figure 1.4: Positioning of histone variants on chromosome structure. Different
chromosomal regions are occupied with distinct histone variants. E.g CENP-A
is a variant of H3 and predominantly found in centromeres to guide chromosome
segregation. (adapted from Banaszynski et. al,Developmental Cell, 2010)
Histone variant macroH2A is another conserved histone variant whose N-terminal
region shares 60% of homology with canonical H2A. C-terminal domain of
mH2A contains a ”macro” globular domain sized 30kDa. Function of mH2A on
chromosome X inactivation is one of the best identified functions [60]. Regulation
of genomic imprinting mediated by heterochromatin structure has been strongly
associated with mH2A [61]. In recent years several studies showed that histone
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variants also play critical roles in cellular reprogramming and differentiation.
For instance, histone mH2A.2, acts as a barrier between differentiated and
pluripotent state of cells [62]. Furthermore, deletion of mH2A results in disrupted
differentiation patterns in human ESCs [63].
All of these works together indicates potential important roles for histone variants
in reprogramming which is still largely undiscovered. Future studies focusing on
how these variants take role in differentiation and transdifferentiation would be
a great leap for regenerative medicine.
1.3 Specific aims
Our studies constitutes the initial phase of a framework program aiming
the establishment of a hepatocellular therapy program based on the use of
hepatocytes obtained by direct differentiation of fibroblasts.
The specific aims of this master thesis were the following:
1- Establishment of a hepatocyte transdifferentiation protocol using SV40 Large
T-antigen immortalized mouse embryonic fibroblasts
The reasons for adopting this procedure are as stated: first, immortalized
cells provide unlimited supply for reprogramming and differentiation; secondly,
although p19 -/- MEFs has been utilized in direct hepatocyte differentiation,
effects of both pRb and p53 deletion has not been evaluated for MEF
differentiation into hepatocytes; finally, it is also unknown whether Large
T-antigen immortalized MEFs can be successfully transdifferentiated into
hepatocyte like cells. Therefore we decided to focus on this approach by adopting
previously described system. Three transcription factors, Hnf4α, Foxa2 and
Foxa3 has been transduced into MEF cells separately, and in combination of
Hnf4α+Foxa2 and Hnf4α+Foxa3.[24] To best of our knowledge, same system has
not been tested on SV40 immortalized MEFs previously.
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2- Preliminary work aiming at obtaining mouse models to study role of histone
variants in fibroblast-to-hepatocyte transdifferentiation
Since roles of histone variants on differentiation is largely unknown, we aimed
at obtaining appropriate mouse models lacking major histone varaints. These
variants are H2AZ.1, H2AZ.2, H3.3A, H3.3B, mH2A.1 and mH2A.2. Except
mH2A.1, all other mice strains carries inducible knockout allele provided by LoxP
sequences which flanks critical exons. mH2A.1 mice are permanently knockout.
Knockout of variants is likely to affect MEF-to-hepatocyte differentiation
positively or negatively.
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Chapter 2
Materials & Methods
2.1 Materials
2.1.1 Genes and plasmids
The retroviral vectors carrying the transcription factor coding sequence were
ordered from Addgene. These pGCDNsam-IRES-GFP vectors carry retroviral
5’ and 3’ long terminal repeats flanking the insert gene and Internal Ribosomal
Entry Site sequence followed by GFP coding sequence. Retroviral plasmids were
submitted by Atsushi Suzuki.[64] The genes coding for transcription factors were:
mouse HNF4A, FOXA2 and FOXA3.
The Cre expressing retroviral MSCV-CreERT2-Puro vector was kindly provided
provided from Institut Albert Bonniot-FRANCE. Retroviral vector carries 5’ and
3’ long terminal repeats (LTRs) of Mouse Stem Cell Virus lacking Gag-Pol and
Env gene which are required for competent viral partical production. CreERT2
gene is inserted between two LTRs and codes a fusion protein Cre flanked by two
estrogen responsive peptides; ERT.
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2.1.2 Cells used in reprogramming
Immortal MEF cells were provided in two genotypes: Wild Type (Wt) and H3.3A
F/F. Particular exons of histone variant alleles H3f3a and H3f3b are flanked by
LoxP sequence. Cre induction in H3.3A MEFs leads to exon excision and gene
knockout subsequently. There are also other SV40 immortalized MEFs with
followed genotypes: H2AZ.1 F/F, H2AZ.2 F/F, H2AZ.1& H2AZ.2 F/F, H3.3A
F/F, H3.3B F/F, H3.3A -/- and H3.3B -/-. These cells are immortal but do not
contain Cre-recombinase expression.
Phoneix 293 cells were provided from Institut Albert Bonniot-FRANCE.
Retroviral plasmids are lack of Gag-Pol and Env gene, which are required for
production of complete viral particles. Phoneix 293 is Hek293 derived cell
line stably transduced by Gag-Pol and Vesicular Stomatitis Virus-G envelope
glicoprotein (VSV-G). Transfection only with retroviral vector is enough to
produce replication deficient viral particles.
To verify correct protein expression of retroviral plasmid with western blot,
Hek293 cells was used for transient transfection protocol.
2.1.3 Cell culture
Immortal MEFs are cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) low glucose supplemented with final concentration of; 10% FBS,
2mM L-Glutamine, penicillin/streptomycin 25 g/ml and non-essential amino
acids. After viral transduction of MEFs , cells cultured in DMEM:F12
(50:50) medium supplemented with 10% FBS, 2mM L-Glutamine, 25 g/ml
penicillin/streptomycin, Non-essential amino acids, 1 g/ml insulin, 1 M
dexamethasone, 10mM nicotinamide, 50 M β-mercaptoethanol, 20 ng/ml
hepatocyte growth factor and 20 ng/ml epidermal growth factor. 0,05% Trypsin
used for trypsinization. For transfection of Hek 293 and Phoneix 293 cells,
Poly-Ethyleneimine (PEI) was used with the ratio of 1:3 (g DNA: g PEI). The
18
10cm plates were coated with poly-l-lysine 100 g/ml for phoneix 293 cell culture.
To culture reprogrammed cells, rat tail collagen type I, 5 ug/ml was used for
coating of 6 well plate.
2.1.4 Primers
The primers used in genotyping is listed below as table 2.1.
Table 2.1: Primer pairs used to identify genotypes of the transgenic mouse
colonies
Allele Primer
H2AZ1 LoxP F GCTACCATTGCTGGTGGTGGTATGTCA
H2AZ1 LoxP R TGTGTGGGATGACACCTAGGAGAGGG
H2AZ1 Knockout F CGTCGGAGCTTCAGCACGGTCC
H2AZ1 Knockout R TGTGTGGGATGACACCTAGGAGAGGG
H2AZ.2 LoxP F CCACGTAATGAGATCCAGTGCCCT
H2AZ.2 LoxP R CATGCACCTGCCATTATGTCTGGTA
H3.3A LoxP F TTTGCAGACGTTTCTAATTTCTACT
H3.3A LoxP R ATATCGGATTCAACTAAAACATAAC
H3.3A Knockout F TTTGCAGACGTTTCTAATTTCTACT
H3.3A Knockout R AAATGCCCCACCACTGCCCAGC
H3.3B LoxP F TCCTCATTCTACCACATGTTCA
H3.3B LoxP R TCAATCTAGGCCTAAGACCAAA
H3.3B Knockout F CTGCCCGTTCTGCTCGCCGATT
H3.3B Knockout R TCAATCTAGGCCTAAGACCAAA
mH2A.1 knockout 1 CCACCACACCCAAGCCATAGTGCC
mH2A.1 knockout 2 GTCACAGGATGAAATGTGCGAAGC
mH2A.1 knockout 3 GCTGGACGTAAACTCCTCTTCAGAC
mH2A.2 LoxP F TTCCACACAGCTACTGAGATGTGCC
mH2A.2 LoxP R TCAGCACAGGGGCTCAAAATACCAG
ROSA26 LacZ 1 AAAGTCGCTCTGAGTTGTTAT
ROSA26 LacZ 2 GCGAAGAGTTTGTCCTCAACC
ROSA26 LacZ 3 GGACCGGGAGAAATGGAT
TTR::Cre F CCTGGAAAATGCTTCTGTCCGTTTGCC
TTR::Cre R GAGTTGATAGCTGGCTGGTGGCAGATG
Internal Control F AGAGGGTCAGCTGAGCAAAA
Internal Control R GCTGGGTAAGGCTGAAAGTG
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2.1.5 Antibodies
Primary antibodies were: α-mouse Hnf4α (Mouse monoclonal, abcam), α-mouse
Foxa2 (Rabbit polyclonal, abcam), α-mouse Foxa3 (Rabbit monoclonal, abcam),
α-mouse Serum Albumin (Rabbit Polyclonal, abcam), α-mouse E-cadherin
(Mouse monoclonal, abcam), α-mouse Vimentin (Rabbit monoclonal, abcam).
Secondary antibodies were: α-mouse HRP, α-rabbit HRP, α-mouse Alexa 568,
α-mouse Alexa 488, α-rabbit Alexa 568, α-rabbit Alexa 488.
2.1.6 Periodic Acid Schiff Staining (PAS)
Periodic Acid Schiff (PAS) staining kit (abcam) used for detection of
polysaccharides in tissue and cell. Kit contains: Periodic Acid solution, Schiff’s
solution, Eosin, Bluing Reagent and Light Green Solution.
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2.2 Methods
2.2.1 Plasmid amplification
The plasmids ordered from Addgene arrived as bacterial stabs in conditioned
LB agar. These stabs were streaked on fresh LB agar which contains ampicillin
100g/ml, and incubated at 37 C◦ overnight. Next day, single colonies were picked
and incubated in LB medium containing ampicillin 100 g/ml at 37 C◦ in shaker.
The next day, plasmids were isolated by using midiprep kit (Machery-Nagel).
2.2.2 Western blot
Total protein was isolated from transiently transfected HEK293 cells by using
RIPA buffer supplemented with Protease inhibitor mix, Sodium Orthovanadate
and Sodium Fluoride. Protein concentrations were calculated with BCA assay
kit. 30 g protein from each samples were loaded on SDS-PolyAcrylamide Gel
with stacking (pH 6,8) 8%, resolving (pH 8,8) 10% density. Samples were run
30 minutes in stacking gel at 80 V ; and, 2 hours in resolving gel at 110V.
Gel was then transferred to PVDF membrane 2 hours with wet transfer at 400
mA. For blocking, membranes were incubated with 10% Milk powder dissolved
in 0,05% TBS-T, 1 hour at room temperature. Primary antibodies α-Hnf4α,
α-Foxa2, α-Foxa3 and E-cadherin were diluted with 1:1000 concentration in
blocking and membranes were incubated with primary antibody overnight at
+4 C◦ . Secondary antibodies α-Mouse and α-Rabbit were diluted in blocking
medium at 1:5000 and membranes were incubated with secondary antibody 1
hour at room temperature. After each incubation, membranes were washed with
0,05% TBS-T three times. After last wash, ECL kit solutions; Luminol and
Phenol were mixed with 1:1 ratio and put on membrane for 5 minutes in dark.
Membrane was then visualized under chemiluminescent detector for 30 seconds,
1 minute and 5 minutes.
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2.2.3 Retrovirus production
Before Phoneix 293 cells were plated, 10 cm plates were coated with Poly-l-lysine.
Phoneix 293 cells were cultured under standard cell culture conditions (DMEM,
10% FBS) and seeded 80% confluency on a 10cm plate the day before plasmid
transfection. At the day of transfection, 293 Phoneix cells reach around 90-100%
confluency, which increase the yield of viral particle. 10 g retroviral expression
vectors (pGCDNsam-Hnf4α, Foxa2, Foxa3 and MSCV-CreERT2) and 2 g VSV-G
envelope plasmid was added in 1ml Opti-MEM, serum reduced culture medium.
According to the ratio of DNA:PEI, 36 g PEI was added to the DNA-OptiMEM
mixture and vortexed. After 15 minutes, DNA-PEI-OptiMEM mixture was given
to the Phoneix 293 cells under standard culture conditions (Figure2.1). After 24
hours of transfection, the medium was replaced by 5ml of fresh medium. After 48
hours of transfection, the GFP expression was checked under inverted fluorescent
microscope. Existence of GFP indicated successful transfection. In the same day
(after 48 hours of transfection) supernatant was collected and stored in -20 as
aliquots.
2.2.4 Viral delivery of genes
Immortal MEF cells were cultured under standard cell culture conditions
(DMEM, 10% FBS). One day before viral transduction, cells were seeded on 12
well plates at 20% confluency. Just prior to viral introduction, hexadimethrine
bromide (Polybrene) was added to viral supernatant with final concentration of
4 g/ml. 500 l each supernatant was combined with polybrene and added to
wells (Figure2.1). Hnf4α, Foxa2, Foxa3 only and CreERT2 wells received only
regarding plasmids. Hnf4α+Foxa2 and Hnf4α+Foxa3 wells received 500 l of each
vectors (total 1000 l). This protocol serially repeated in every 2 hours, total three
times. Two hours after last infection, fresh DMEM with 10% FBS was added
to the wells. 24 hours after last infection medium was replaced by hepatocyte
differentiation medium without growth factors. Cell medium was replaced with
fresh medium.
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Figure 2.1: Virus production and transduction protocol
2.2.5 Culture of iHep cells and colony selection
Before transduced cells were replated, 6 well plates were coated with collagen
type I. One week after viral transduction, reprogrammed cells were replated
into collagen coated 6 well plates at 1/20 and 1/200 concentrations in order to
observe single colony formation and colony selection. At this stage, differentiation
medium was supplemented with EGF and HGF. After first replating, colony
forming cells were observed under inverted brightfield microscope. Colony
selection was performed according to cells morphology. In heterogenous cell
population, epithelial-like cells were considered as differentiated and marked.
After medium is drawn, single colonies were selected with pipette trypsinization
and replating to cover slipped, collagen type-I coated 12 well plate.
2.2.6 Mouse colony formation
All strains were transferred from Grenoble-FRANCE and Lyon-FRANCE in
September 2013. In animal house of Bilkent University-Ankara, there are six
transgenic mouse strains all of which are conditionally or permanently knockout
for histone variants: H2AZ.1, H2AZ.2, H3.3A, H3.3B, mH2A.1 and mH2A.2.
Except mH2A.1 all strains carry transgenic LoxP sequences which flanks critical
exons of regarding genes. mH2A.1 knockout mouse strain represent permanently
deleted gene of mH2A.1 (Table 2.2).
There is one more transgenic mouse strain which carries ectopic Cre gene under
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the control of ”Transthyretin (TTR)” promoter, which is found exclusively in
liver and plexus of the brain. Cre gene is constantly expressed in liver but
cannot perform a recombination due to structural modification of Cre protein.
Its expression is controlled by ”murine estrogen receptors(MER)” sequences
flanking Cre gene; and, when expressed, Cre translocates into the nucleus in the
presence of 4-OHT (hydroxytamoxifen). Same straine carries LacZ expression
under the control of ubiquitous ROSA26 promoter. Expression is absent in
normal conditions, since this transgenic allele has a stop cassette flanked by LoxP
sequences, only active Cre recombinase can induce LacZ expression. Therefore,
cre expression can be traced in this strains.
Table 2.2: List of mouse transgenic mouse strains and available transgenic alleles
Transgenic Strain Name Allele
H2AZ.1 Flox, knockout, wild type
H2AZ.2 Flox, wild type
H3.3A Flox, knockout, wild type
H3.3B Flox, knockout, wild type
mH2A.1 knockout, wild type
mH2A.2 Flox
TTR::CreTAM, ROSA26 Cre+, R26R+, R26R wild type
Name of the mouse strains and alleles in gene pool. Flox means LoxP sequence
flanking regarding gene (Flanking LoxP). Kockout is deleted allele. Cre+ gives
qualitative result of genotyping, since Cre insertion into mouse genome is not
targeted and cannot be detected homozygosity with single PCR. R26R represents
transgene for ROSA26-Lox-STOP-Lox-LacZ construct.
2.2.7 Mouse breeding
Breeding was applied as crossing of mice inside the strain. Crossing procedure
is as followed: one male to two-three female are placed in the same cage.
Three weeks after the copulation plug is observed, female mice give births.
Maximum ten days after birth, tail-finger samples are collected from infant mice
for genotyping. One month after birth, litters are weaned and separated to
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different cages. If there is a reproductive problem in the colonies, wild type strains
are crossed with transgenic strains to expand genetic pool and reproductive
capacity.
2.2.8 Genomic DNA extraction from mouse tissues
Tail samples are incubated in Tail Buffer and Proteinase K in 55 C◦ overnight
(shorter for cell suspension). Saturated NaCl solution is added to the samples to
precipitate proteins. After centrifugation, DNA is precipitated with isopropanol,
70% Alcohol and 100% alcohol sequentially. After alcohol is dried, DNA pellet
is reconstituted with sterile, ultra pure water. DNA concentration is measured
with NanoDrop (Thermo Scientific).
2.2.9 Genotyping with PCR
Genotyping analyses are performed by conventional Polymerase Chain
Reaction(PCR) on genomic DNA. All LoxP containing alleles are genotyped with
CRE40 program and steps are as followed: Initial Denaturation: 95 C◦, 3 min.
First 2 Cycle: Denat, 95 C◦, 1 min; Anneal 58 C◦, 1 min; Extension, 72 C◦, 1
min. Next, 38 cycle as follows: : Denat, 95 C◦, 30 sec; Anneal 58 C◦, 30 sec;
Extension, 72 C◦, 30 sec. Final extension; 72 C◦, 3min. Next, samples were
cooled down to 10 C◦.
For R26R alleles ”ROSA” program is used: Initial Denaturation: 95 C◦, 3 min.
32 Cycle; Denat, 95 C◦, 30sec; Anneal 65 C◦, 1 min; Extension, 72 C◦, 2 min.
Final extension; 72 C◦ 10min. Next, samples were cooled down to 10 C◦.
For permanently knockout alleles ”LONG” program is used: Initial Denaturation:
95 C◦, 3 min. 32 Cycle; Denat, 95 C◦, 30sec; Anneal 58 C◦, 1 min; Extension, 72
C◦, 2 min. Final extension; 72 C◦ 10min. Next, samples were cooled down to 10
C◦.
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PCR products are run on 1,5% Agarose gel at 80V for 40 minutes. Safe Green
(abm good) is utilized for DNA visualization.
In gel electrophoresis, LoxP containing allele gives approximately 150-200bp
higher bands compared to Wild Type alleles. Permanently knockout allele primers
target complete exone from both sides. Thus, PCR product giving around 1500bp
for complete exon yields 500bp for deleted version. For ROSA strain, lighter
band, which is 340bp gives mutant allele while 650bp gives wildt type allele.
2.2.10 Purification of MEFs and immortalization
H2AZ.1 F/F, H2AZ.2 F/F, H2AZ.1& H2AZ.2 F/F, H3.3A F/F, H3.3B F/F,
H3.3A -/- and H3.3B -/- genotyped male and Female mice are placed in a cage and
every day copulation plug is checked. The day plug is detected, considered as day
zero. Thirteen days after, embryos (E13) are removed from female mouse under
anesthesia. Head, internal organs and feet of embryos discarded. Remaining
body is cut into small pieces. In a falcon tube, pieces are incubated with trypsin
in +4 C◦ . Next day, suspension is incubated at 37 C◦ for 10-20 minutes. Culture
medium and DNaseI is added and incubated at 37 C◦ . Cells are centrifuged and
passaged in culture medium. At P1, MEFs are frozen for further process. To
immortalize MEF cells, SV40 Large T antigen containing retroviral vectors are
delivered to the Wild Type MEFs and cells were selected with Zeocin.
2.2.11 Inducible Cre-LoxP system in MEFs
Immortal MEF cells with Wt and H3.3A genotype are transduced with Cre-ERT2
containing retroviral supernatants. Next, cells are cultured with puromycin
for selection of genes. Cre-ERT2 fused protein is constantly expressed in host
genome; however, it can only be induced with hydroxytamoxifen (4-OHT).
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2.2.12 Immunofluorescent staining
Cells seeded on 12 well plate were fixed with 4% paraformaldehyde 5 minutes.
Cells were washed with 1X PBS three times. Fixed cells were permeabilized
with 0,3% TritonX(in PBS) for 5 minutes and washed with 1X PBS three times.
Blocking was performed with 10%FBS in 0,1% PBS-T (Tween) 1 hour in room
temperature. Primary antibodies were diluted in blocking solution in following
concentrations: E-Cadherin, 1:200; Vimentin, 1:200; Serum albumin, 1:50; and,
cells were incubated overnight at +4 C◦. Primary incubation is ended by washing
with 0,1% PBS-T three times. All secondary antibodies were used in 1:500
dilution in blocking medium and cells were incubated 1 hour in room temperature.
After washing with 0,1% PBS-T three times, 1/10.000 DAPI, diluted in ddH2O,
was used to stain nuclei. Finally coverslips were mounted on slides with mounting
medium.
2.2.13 Periodic Acid Schiff’s staining (PAS)
Staining protocol was applied as indicated in Abcam’s manual. Cells were
immersed in periodic acid solution for 5 minutes then washed with distilled water.
Cells immersed in Schiff’s solution for 15 minutes then washed with tap and
distilled water. Coverslips then stained with hematoxylin for 30 seconds then
washed with tap and distilled water. Bluing reagent was applied 30 seconds then
washed with distilled water. Light green solution was applied for 2 minutes then
washed with distilled water. Cells dehydrated with graded alcohols, finally with
xylene and mounted with entellan on slides.
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Chapter 3
Results
3.1 Direct induction of hepatocyte-like cells
from immortalized Mouse Embryonic Fibroblast
3.1.1 Verification of retroviral plasmid gene expression
The retroviral vector plasmids were transformed into competent bacterial DH5α
strain and amplified in antibiotic resistant medium and purified with midiprep
kit. These plasmids were previously published, and they contain GCsap retroviral
vector sequence comprising modified Long Terminal Repeats(LTRs) of Murine
Stem Cell Virus(MSCV) [24, 64]. The vectors carry Hnf4α, Foxa2 and Foxa3 open
reading frames for expression, which is followed by an Internal Ribosomal Entry
Site (IRES) and a Green Fluorescent Protein (GFP) coding sequence. Hek293
cells were transfected with given plasmids and western blot was performed.
Hnf4α, Foxa2 and Foxa3 proteins were detected at 53 kDa, 52k Da and 37 kDa
respectively as seen in Figure 3.1. This result indicates that the plasmids are
intact and able to express correct proteins in transient transfection protocol.
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Figure 3.1: Plasmid maps and plasmid verification by western blot. a:
pGCDNsam vectors are retroviral plasmids carrying open reading frame of Hnf4α,
Foxa2 or Foxa3 genes followed by a IRES-GFP sequence. b: Western blot results
of Hek293 cell transfection with regarding vectors. Black arrows indicate expected
band sizes.
3.1.2 Viral delivery of transcription factors
Immortal MEF cells were cultured in 12 well plates and transduced serially three
times with viral supernatants of Hnf4α, Foxa2 and Foxa3. Viral transduction
of MEF cells with Hnf4α+Foxa2 or Hnf4α+Foxa3 factors has been previously
shown to give rise to iHEP cells [24]. Same transcription factor combinations
were adopted and additionally we transduced MEFs with single gene, Hnf4α,
Foxa2 and Foxa3. Combined transduction was performed simply by mixing viral
supernatants 1:1 ratio. 24 hours after infection, cell medium was changed to
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Figure 3.2: Evaluation of viral transduction efficiency by GFP expression. Each
picture shows GFP expression of transuduced MEF cells and uninfected MEF
cells.
differentiation medium without HGF and EGF. Two days after viral delivery,
infection level was evaluated by GFP expression. Most of cells were GFP positive
with varying levels of fluorescence. Transduced cells were cultured one week
under differentiation conditions. After one week, cells were highly confluent and
expressed GFP as in Figure 3.2.
3.1.3 Morphological changes of transduced MEFs
One week after viral transduction, cells were replated on collagen-I coated
plates. From this point, cells were cultured with EGF and HGF supplemented
differentiation medium. One week after first passage, epithelial-like colonies
formed in all transduced cells (Figure3.3). In these wells, MEFs extensively
lost their spindle-shaped morphology and gained a polygonal-shaped cytoplasmic
organization. Moreover, loose cell-to-cell adhesion and lack of cell organization
in MEFs transformed into a more densely organized colonies. Cells
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showing morphological changes were detected in clusters surrounded by larger
spindle-shaped cells.
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Figure 3.3: Morphological changes of MEFs. a: Cells infected with single Hnf4α,
Foxa2 and foxa3 factors shows epithelial like colonies. Note that, cells in the
colonies are polygonal shaped and tightly attached each other. b: Hnf4α+Foxa2
and Hnf4α+Foxa3 combinations also show densely packed colony morphology.
Also note that the colonies are larger and well demarcated from untransformed
spindle-shaped cells. Arrowheads show the colonial structures. Scale bars: 100x
column: 500m, in 200x column 200 m.
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Epithelial-like cell characteristics are best observed in Hnf4α+Foxa2 and
Hnf4α+Foxa3 transduced wells, since number of the epithelial like colonies were
higher and these colonies were finely sequestered from mesenchymal-like cells.
Furthermore, Hnf4α+Foxa2 and Hnf4α+Foxa3 colonies showed epithelial basal
membrane-like organization on colony edges (Figure3.3). At this stage colonies
were picked from Hnf4α+Foxa2 and Hnf4α+Foxa3, and replated into collagen
coated plates.
These results indicate that all transductions have a significant effect on
mesenchymal cell morphological characteristics. In the reference study, epithelial
colonies were first observed within 3 weeks after first passage. However, we
first detected epithelial shaped colonies as early as one week after replating [24].
Although these results were promising, morphological changes alone cannot be
interpreted as complete differentiation of MEFs. Epithelial characteristics should
be further characterized with molecular markers.
3.1.4 Epithelial characterization of transduced MEFs
Epithelial cells have diverse functions in organism and show special type of
organization. Adherent junction is the main adhesion type in epithelial cells.
On the contrary, mesenchymal cells are highly motile and express cytoskeleton
markers predominantly. As the cells gain epithelial characteristics, mesenchymal
markers decrease and epithelial markers increase. E-cadherin is an essential
transmembrane protein which predominantly found in adherent junctions. Its
extracellular domain is self-associate which allows two cells to attach; and, this
adhesion type is highly expressed ib epithelial cell. Therefore E-cadherin is
a reliable epithelial marker [65]. Conversly, vimentin, a cytoskeleton marker,
is highly expressed in mesenchymal cells; and, its expression is absent or
strongly diminished in epithelial cells. Thus, in differentiation studies, epithelial
characteristics can be monitored by changes in E-cadherin and vimentin levels.
In our study, induced cells were co-immunostained with both vimentin and
E-cadherin antibodies and labeled with fluorescent secondary antibodies. While
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the uninfected MEF cells showed intact vimentin expression, barely diminished
vimentin expression was observed in Hnf4α-only and Foxa3-only transduced
MEFs. Vimentin expression is further diminished in Foxa2-only, Hnf4α+Foxa2
and Hnf4α+Foxa3 transduced MEFs (Figure3.4).
On the contrary to mesenchymal marker expression, E-cadherin was not observed
in expression in Hnf4α-only, Foxa2-only, Foxa3-only and uninfected MEFs.
However, Hnf4α+Foxa2 and, to a lesser degree, Hnf4α+Foxa3 co-infected MEFs
showed strong E-cadherin expression which is localized to cell-to-cell junction
boundaries (Figure3.4).
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Figure 3.4: Immunofluorescent staining of epithelial and mesenchymal marker in
transformed cells. Mesenchymal marker vimentin expression is barely diminished
in Hnf4α and Foxa3 only transduced MEFs. However, combined infected cells
with, Hnf4α+Foxa2 and Hnf4α+Foxa3 shows greater decrease in vimentin.
Epithelial marker E-cadherin is almost completely absent in Hnf4α, Foxa2 and
Foxa3 only infected cells. Contrarily, high levels of E-cadherin can be observed
in Hnf4α+Foxa2 infected cells, and to a lesser degree in Hnf4α+Foxa3cells. Note
that cells showing high E-cadherin levels are densely contact each other in clusters.
Scale bars: 100m.
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E-cadherin expression was also tested with western blot analysis. Confirming
the immunofluorescence data, highest E-cadherin expression was observed in
Hnf4α+Foxa2, and to a lesser extend in Hnf4α+Foxa3 transduced immortal
MEFs (Figure3.5). Interestingly, Foxa3 only infected MEFs showed slight
increase in E-cadherin expression, which was not confirmed in immunostaining
experiment. Vimentin expressions were inversely correlated with E-cadherin also
in western blot analysis. However, the decrease in vimentin was very low and best
observed in Hnf4α+Foxa2 infected MEFs. These results suggest that, infection
Figure 3.5: Western blot analysis of E-cadherin and vimentin expression. Only
co-infected MEFs shows highest E-cadherin expression. Loss of vimentin is best
observed in Hnf4α+Foxa2 infected MEFs. P5, passage number.
of SV40 immortalized MEFs with single transcription factor may induce loss of
mesenchymal characters to a limited degree as evidenced by immunofluorescence
and western blot analysis. Immunofluorescence shown slight decrease in vimentin
for Foxa2-only infection ; but, it is not enough to express epithelial specific
E-cadherin marker. Co-infection of MEFs with Hnf4α+Foxa2 and Hnf4α+Foxa3
combination could have diminished the vimentin and induced E-cadherin, which
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is best observed in immunofluorescence. The reason why vimentin is barely
diminished in western blot compared to immunostaining can be best explained by
heterogenous differentiation status of cells. In summary, the highest mesenchymal
to epithelial transition phenotype was observed in Hnf4α+Foxa2 combination.
3.1.5 Identification of hepatocyte specific markers
Mature hepatocytes are responsible for expression and secretion of blood serum
albumin into blood. This unique function has been utilized as a hepatic
differentiation marker [66]. Thus, induced MEF’s were immunostained with
anti-mouse serum albumin after fifth passage.
Hnf4α, Foxa2, Foxa3-only infected MEFs were negative for albumin fluorescence.
However, Hnf4α+Foxa2 and Hnf4α+Foxa3 co-infection resulted in albumin
positive islets (Figure3.6). Although strong albumin expression was observed
in islets, the overall albumin positive cells were not widespread over the field.
Correlated with previous report, this results indicate that the immortalized MEF
cells can only be differentiated into hepatocyte-like cells with Hnf4 together with
either Foxa2 or Foxa3 transcription factors [24]. Transduction solely with Hnf4,
Foxa2 or Foxa3 is not enough to induce liver specific protein expression even
in the conditioned hepatocyte medium. Albumin positive cells in small clusters
suggest a incomplete differentiation process for rest of the cells in colonies.
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Figure 3.6: Immunofluorescent staining of albumin in transduced MEFs. Except
co-infection with Hnf4α+Foxa2 and Hnf4α+Foxa3 combination, no Albumin
positive cell was observed. Note that albumin positive cells in Hnf4α+Foxa2
and Hnf4α+Foxa3 infected cells show clusters.
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3.1.6 Glycogen storage of induced MEFs
Although albumin expression represent a liver specific function, activation of a
single is not sufficient to identify a functional metabolism of the hepatocytes. One
of the major physiological role of liver is to deposit glucose in form of glycogen
polymers. Conversely, the blood glucose levels can be regulated in hepatocytes
by breaking down of the glycogen into glucose and release into bloodstream [67].
Besides, process of glycogen storage from circulating glucose requires organization
of complex gene expression pattern peculiar to hepatocytes. Therefore, glucose
uptake and storage in the form of glycogen is considered as one of the main
criteria in obtaining hepatocytes.
Periodic Acid Schiff’s (PAS) staining method shows polysaccharides in fixed
tissues and is used to show glycogen storage in differentiated hepatocytes
[12, 27, 23, 68]. In our study, we have performed Periodic Acid Schiff’s staining
in order to visualize glycogen storage of induced hepatocytes.
After passage four, induced MEFs were evaluated for glycogen storage levels. PAS
staining gives acidic cytoplasmic magenta color which contrast with blue basic
stain of cytoplasm and nucleus. The cell clusters stained with magenta colored
cytoplasm were visible at lower magnifications. Foxa2-only, Foxa3-only and
uninfected immortal MEF cells showed no PAS staining. However, Hnf4α+Foxa2
and Hnf4α+Foxa3 infected MEFs were strongly stained with magenta color.
Hnf4α+Foxa3 transduced cells showed slightly less staining than Hnf4α+Foxa2
(Figure3.7). Furthermore, cytoplasm of HNF4α-only transduced cells were
stained with PAS very slightly compared to fibroblasts, which is visible under
400x magnification.
Correlated with epithelial characterization results,positive PAS staining in
Hnf4+Foxa2 and Hnf4 +Foxa3 co-infected immortal MEFs suggest that double
factor transduced cells show glycogen storage. Additionally, single transcription
factors were insufficient to stimulate molecular pathways regarding glycogen
storage except Hnf4α. MEFs transfected only with Hnf4α gave very light PAS
staining in several cells (Figure3.7). This result was not surprising, since previous
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Figure 3.7: PAS staining of induced MEFs. Unlike the single transcription factor
infected MEFs, , Hnf4α+Foxa2 and , Hnf4α+Foxa3 shows extensive PAS staining
at lower magnification (100x and 200x column). At higher magnifications,
cytoplasmic PAS staining in individual cells are visible particularly in H+F2,
H+F3 and Hnfα only infected cells. Black arrowheads show cytoplasmic PAS
stain. Scalebars: 200 m in 100x and 200x column; 100 m in 400x column.
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data shown that deletion of Hnf4α affects glycogen storage related genes and
causes lack of PAS staining. [69] In literature, effects of Foxa3 on development
and function of the liver was reported [70, 71]. Deletion of Foxa3 resulted no
abnormal liver development and its expression is compensated by Foxa1 and
Foxa2 proteins. However, its deletion disrupts Glut2 expression in adult mice.
Absence of glycogen stain after single Foxa3 overexpression indicates it does not
play a direct role on glycogen storage. Although the Foxa2 is indispensible for
healthy liver development, its overexpression leads to glycogen storage defects
[72]. Consistent with these data, overexpression of Foxa2 alone leads no glycogen
storage in MEFs.
In conclusion, overexpression of individual transcription factors cannot
dramatically affect glycogen storage. However, co-infection of Hnf4α together
with either Foxa2 or Foxa3 positively regulates glucose uptake and storage in the
form of glycogen. Thus, combination of these factors are able to finely orchestrate
a complex energy metabolism, which is a characteristic for functional hepatocyte.
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3.2 3.2 Preliminary results on genetically
modified mice
3.2.1 Mouse colonies and genotyping
Mouse strains were provided as mentioned in methods sections. Most of these
mice have functioning gene in their genome; but, a critical exon is flanked by LoxP
sites which can be deleted with Cre recombination. One exception is mH2A.1
strains that, these animals permanently knockout for this gene.
All genotyping procedure was performed by conventional PCR method on
genomic DNA. Primers targets specific genomic sequences in each strain.
Conditionally knockout strains contain LoxP sequences flanking a critical exon.
A primer pair flanking one of the loxP sequence can amplify 100-200 bp sequence
more than wild type allele, which can be detected as a band shift in agarose gel
electrophoresis (Figure3.8). If there is a permanent knockout allele of these gene,
a primer pair flanking whole exon is used for genotyping. Cre primers target
directly the gene body. In ROSA26 strains, transgenic gene gives smaller bands
compared to wt allele which can be also detected in gel electrophoresis.
Mouse genotyping results are preliminary data which will be utilized in future in
vitro and in vivo studies. Especially, primary cell lines derived from these strains
would be an invaluable tool for direct differentiation of hepatocyte.
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Figure 3.8: Gel electrophoresis images of genotyping. Note that LoxP genotyping
results 100-200 bp band shift compared to wild type. On the contrary, ROSA
strain has lower size bands for transgenic allele compared to wild type. Wt, wild
type; KO, knockout; L-, knockout allele. Each number above the gel picture
represents identity of an animal.
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3.2.2 Infection of H3.3A F/F MEFs with Cre-ERT2
expressing retroviral vector
In order to show effects of histone variants, primary MEFs were isolated from
H3.3A F/F, H3.3B F/F, H3.3A -/-, H3.3B -/-, H2AZ.1 F/F, H2AZ.2 F/F and
H2AZ1/H2AZ2 F/F mouse strains. These cells were infected with retroviral
vector carrying SV40 large T-antigen open reading frame sequence, and cells
were selected with zeocin. In first trial we continued our study with immortal
H3.3A F/F MEFs.
To excise LoxP flanked exon using Cre mediated recombination in future studies,
we have used Cre-ERT2 expressing retroviral vectors. The open reading frame is
composed of Cre recombinase gene which is fused to a modified estrogen receptor
protein. Under normal conditions, Cre is expressed continuously, but cannot
translocate to nucleus. In case of 4-Hydroxytamoxifen (4-OHT) administration,
Cre translocates to nucleus and initiates recombination by excising exon between
two LoxP sites. Vector also contains mammalian puromycin resistance selection
marker. We infected transgenic cells with retroviral vectors and selected with
puromycin.
We evaluated the integration of viral gene into MEF genome by using conventional
PCR method. Genomic DNA was extracted from both wild type and transgenic
MEFs. LoxP sites in mutant MEFs makes about 170 bp difference compared to
wild type as seen in (Figure3.9), lower panel. The presence of Cre was seen at
650 bp in gel electrophoresis.
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Figure 3.9: Conventional PCR from genomic DNA. Lower panel shows genotyping
of MEFs. Mutant MEFs show about 170 bp difference caused by LoxP sequence.
In (Figure3.9), upper panel shows presence of Cre gene on the genome (650 bp).
Second primer pair was used as an internal control.
In this set of experiments, primary Mouse Embryonic Fibroblasts isolated from
mice were immortalized and Cre expressing vectors successfully delivered to one
of these strains.
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Chapter 4
Discussion & Conclusion
Direct differentiation of hepatocyte-like cells from mouse and human fibroblast
cells was previously published [21, 24, 23, 27]. All methods are based on over
expression of liver lineage specific transcription factors. One of these reports,
scientists have utilized Hnf4α transcription factor together with either Foxa1,
Foxa2 or Foxa3 to directly differentiate primary mouse embryonic fibroblasts into
hepatocytes [24]. However, same combination of factors have not been tested
on SV40 immortalized MEFs. Although transdifferentiation from p19 knockout
MEFs was mentioned somewhere else, there is no information about how knockout
of both p53 and pRb pathways affect MEF to hepatocyte transition.
In our study, we have isolated and frozen viral supernatants, which may decrease
transduction efficiency. Additionally, serially infections were repeated only three
times. These infection conditions were suboptimal compared to the reference
article, where scientists have used concentrated viral supernatant and infected
cells six to eight times. But, we successfully infected immortal MEFs as shown
in figure3.2. More significantly, we have obtained morphologically differentiated
cells as early as one week after replating of transduced immortal MEFs. However,
same morphological chances from primary MEFs occur in at least three weeks
[24]. This difference can be mainly due to suppressed p53 and pRb pathway,
inactivation of which facilitates dedifferentiation of cells [33].
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Although Hnf4α+Foxa2 and Hnf4α+Foxa3 has been proven to be sufficient for
transdifferentiation, single gene expressions for each factor has not been evaluated
in SV40 immortalized MEFs. Hnf4α is one of the master regulators in liver
development and its deletion has a lethal phenotype in mice[28]. Immortal
MEFs which are infected only with Hnf4α shows limited change in morphology.
However, absence of epithelial marker E-cadherin and absence of albumin
expression (figure 3.4 and figure 3.6) indicates an inadequate differentiation
stage. Contrarily, in previous study, Hnf4α only infection was shown to induce
epithelial-like characteristics in mouse fibroblast cell line NIH-3T3, such as
gaining polygonal shape and E-cadherin expression [69]. This contradiction
may be due to infection efficiency and ectopic expression levels introduced to
fibroblasts. Hnf4α is also a key glucose metabolism regulator in liver and its
absence in adult animals leads to several glycogen storage deficiency phenotype
[29]. Consistently, overexpression of Hnf4α showed little storage of glycogen in
our study.
Hnf3 factors (also named as Foxa factors) belong to winged helix protein family
and have important functions in both developing and adult liver. Both Foxa1
(Hnf3α) and Foxa2 (Hnf3β) deletion gives lethal phenotypes in mice [73, 74].
However, in literature, deletion of Foxa3 was shown to have no severe phenotype
on liver function, which is compensated largely by other liver specific transcription
factors [70].
Foxa2 expression is involved in endoderm derived organ development such as
liver, pancreas and lungs [75, 76, 77]. In a previous report, ectopic expression of
Foxa2 alone was proven to be insufficient to induce E-cadherin expression; but, its
deletion is essential for epithelial to mesenchymal transition [78]. Consistent with
these data, in our study, Foxa2-only infections yielded cells which shows neither
epithelial nor hepatocyte marker. Furthermore, absence of glycogen staining in
Foxa2-only infected cells correlates with a previous report which shows that, over
expression of Foxa2 leads to glycogen storage defects [72]. Similarly, ectopic
expression only with Foxa3 in MEFs resulted morphological changes without any
further epithelial or hepatocyte specific phenotype.
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Besides the transcriptional activation role of Hnf3 (Foxa) family factors, they
can exclusively modify heterochromatin structure with a direct interaction.
This action creates nucleosome free regions locally which facilitates other liver
enriched factors to bind this exposed DNA region [48]. In our study, indeed we
overexpressed Foxa2-only and Foxa3-only factors in immortal MEFs. However,
lack of differentiation in molecular level indicates that, even if these factors
can directly modulate chromatin structure upon binding, additional factors are
required to differentiate immortal MEFs.
Expression of transcription factors in combination of Hnf4α+Foxa2 and
Hnf4α+Foxa3 has shown transition from mesenchymal to epithelial phenotype.
As early as one week after replating, finely demarcated and well growing colonies
were formed in Hnf4α+Foxa2 and Hnf4α+Foxa3 infected MEFs. This data was
further supported with increased E-cadherin and decreased vimentin expressions
by immunofluorescence. With western blot analyses, increased E-cadherin
expression levels were verified in Hnf4α+Foxa2 and Hnf4α+Foxa3 infected cells;
however, only slight decrease in vimentin expression was observed in these cells.
This could be explained by heterogeneity in differentiation levels, since some
MEFs may resist to lose mesenchymal characteristics during differentiation.
Additionally, results indicated that, infection with two factors of Hnf4α+Foxa2
has resulted in higher levels of epithelial molecular markers than Hnf4α+Foxa3,
which is also proven by immunofluorescence and western blot analyses.
Similar changes were also visible in determination of hepatocyte phenotype with
specific function. In glucose uptake experiment, PAS staining results showed that,
Hnf4α+Foxa2 and Hnf4α+Foxa3 combinations yielded highest levels of glycogen
storage. As in epithelial marker staining experiment, Hnf4α+Foxa2 gives more
intensive PAS staining compared to Hnf4α+Foxa3.
Albumin production and secretion is the one of the unique functions of the
liver. Immunofluorescence analysis showed only Hnf4α+Foxa2 and Hnf4α+Foxa3
infected MEFs are albumin positive. Although we have not quantified the
albumin expression levels with flow cytometry, albumin positive cells were
clustered containing few cells. There is no significant difference between
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these two combinations in terms of albumin levels. Sparse albumin positive
clusters indicates that only a subpopulation of cells have undergone complete
differentiation. Decreased reprogramming efficiency could be a potential answer,
since we have repeated viral transduction only three times. This may cause
insufficient gene expression and eventually decreased albumin levels. Another
potential reason could be the immortal nature of MEFs. Since pRb deletion has
been associated with decreased differentiation potential of the cells [36]. In one
transdifferentiation study, immortalization of human fibroblasts with SV40 Large
T-antigen lead to decreased expression of albumin in later passages [27].
Here we used a protocol designed for non-immortalized MEFs into large T
antigen immortalized model. To best of our knowledge there is not study which
differentiate pRb and p53 ablated MEFs into hepatocyte like cells with this
method. The most significant difference was that, time required for differentiation
was decreased in our method using Large T antigen immortalized MEFs.
In second course of the study, we have bred mice strains different genetic
background. Except the one mouse strain with permanent knockout for mH2A.1,
other strains (H2AZ.1, H2AZ.2, H3.3A, H3.3B, mH2A.2) carry konditional
knockout alleles with LoxP. Another strain carries Cre gene expression under
the control of TTR promoter; and, the same strain carries R26R-LacZ allele
for tracking Cre activity. There are well established SV40 large T-antigen
immortalized MEF cells isolated from mice strains: H3.3A F/F, H3.3A -/-, H3.3B
F/F, H3.3B -/-, H2AZ.1 F/F, H2AZ.2 F/F and H2AZ.1/H2AZ.2 F/F. Among
these, we transduced H3.3A F/F cells with controllable Cre expressing retroviral
vector. Genotyping results indicate that cells contain integrated Cre gene and it
is ready for induction of recombination with 4-OHT (hydroxytamoxifen) [79]. To
understand effects of histone variants in hepatocyte transdifferentiation process,
this conditional knockout cell strain is a invaluable tool.
Despite the recent discoveries, role of histone variants are still largely unknown.
Growing amount of articles are defining new roles in reprogramming process.
For example, scientists have discovered that, variant H3.3 has a crucial role in
establishing epigenetic memory in differentiated cells. Its deletion has been found
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to be beneficial for iPSC reprogramming [41]. It would be interesting to see the
effects of H3.3 deletion during direct hepatocyte induction. H3.3 ablation is
likely to contribute this process by helping cells to ”forget” what cell type they
transdifferentiating from.
Direct regulatory effects of Hnf3 factors on chromatin structure strongly implies
a potential relationship with histone variants. One study highly supports this
hypothesis, since cooperation of H2AZ and Foxa2 has been found to create
nucleosome free regions. Furthermore, together they contribute the endoderm
lineage determination [53]. Deletion of H2AZ during hepatocyte reprogramming
would cause a resistence for differentiation.
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Chapter 5
Future Perspectives
First of all, naive wild type MEF culture should be used as control in order to
elucidate effects of SV40 large-T antigen on differentiation.
In this study, we established a direct hepatocyte induction protocol derived
from Large T-Antigen immortalized Mouse Embryonic Fibroblasts. However,
efficiency of viral transduction; E-cadherin and Albumin expression has not been
quantified. As a next step, viral transduction efficiency should be calculated
by Fluorescence-Activated Cell Sorting. After cells are transduced, sequential
differentiation steps occur during differentiation. Using FACS technique to count
vimentin, E-cadherin and albumin positive cells would give us an idea how this
stepwise events progress.
To identify success of hepatocyte differentiation, comprehensive gene expression
profile would be carried out by Q-PCR with the same protocol. Same
quantification should be also performed on endogenous and exogenous expression
levels of given transcription factors.
To establish a method to detect differentiated cells earlier, Cre-ROSA-LacZ
system can be utilized. Cre transgenic mouse strain expresses Cre recombinase
protein under the control of Transthyretin promoter, a liver specific gene. Mouse
embryonic fibroblasts derived from this strain can be immortalized and used for
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transdifferentiation studies. As the cells start to gain liver gene expression profile,
TTR controlled Cre would mediate the excision of stop cassette from ROSA-LacZ
system and differentiated cells can be detected by X-gal staining. With this
method, quantification of efficiency may become much easier.
There are several mouse strains which can be used as a source of MEFs and
different type of somatic cells. Besides the genotyped animals, there are well
established genetically defined immortalized MEF cell lines (H3.3A F/F, H3.3B
F/F, H2AZ.1 F/F, H2AZ.2 F/F and H2AZ.1& H2AZ.2 F/F). As previously
mentioned, Cre-ERT2 retroviral system has been utilized to control knockout
of H3.3A F/F MEFs. Same system would be used for other immortalized cells
due to its convenient inducibility. There is also another Cre expressing method
which uses Adenoviral system for Cre delivery. This system has been successfully
used by taking advantage of non integrating cargo and strong infection potency
of adenoviral vectors [80]. Before advancing to gene knockout studies, Adeno-Cre
system should also be tested for proper Cre expression on primary and immortal
cell lines.
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Appendix A
Standard Solutions and Buffers
10X PBS
• 80 g NaCl
• g KCl
• 8,01g Na2HPO4.2H2O
• 2g KH2PO4
• 1 liter ddH2O pH: 7,4
• Working solution (1XPBS) was prepared by diluting 10XPBS by 10 times
50X TAE Buffer
• 2M Tris Base (242 g)
• 57,1 ml Glacial Acetic Acid
• 50mM EDTA
• Add to 1 lt by ddH2O
64
• Working solution (1XTAE) prepared by diluting 50XTAE.
TAIL BUFFER
• 1% SDS
• 0.1 M NaCl
• 0.1M EDTA
• 0.05M Tris(pH8.0)
10X TBS
• 60.6 g Tris Base
• 87.6 g NaCl
• 1M HCl
• Adjust pH to 7,6 and fill up to 1 Liter ddH2O
• Depending on the procedure, it is diluted to 1X TBS and added either
Tween 20 or Triton-X.
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Figure B.1: Copyright permission for figure in 1.2
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Figure B.2: Copyright permission for figure in 1.3
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